VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Yao on Transplants Beyond Milan Criteria for Liver Cancer

Francis Yao, MD
Published: Friday, Jan 13, 2017



Francis Yao, MD, gastroenterologist and medical director of the Liver Transplant Program at the University of California San Francisco Medical Center, discusses liver transplants beyond Milan criteria for patients with liver cancer.

Over the past 20 years, physicians' knowledge of liver transplants for patients with liver cancer has increased, explains Yao. In 1996, the Milan criteria was published, suggesting that transplanting in early stages of liver cancer is the best way to achieve positive results. The Milan criteria is one single lesion up to 5 centimeters, or 2 to 3 lesions up to 3 centimeters.

The Milan criteria has been questioned over the past couple of years, according to Yao. There have been some cases where patients have been outside of the Milan criteria and responded positively to the transplant treatment.
 


Francis Yao, MD, gastroenterologist and medical director of the Liver Transplant Program at the University of California San Francisco Medical Center, discusses liver transplants beyond Milan criteria for patients with liver cancer.

Over the past 20 years, physicians' knowledge of liver transplants for patients with liver cancer has increased, explains Yao. In 1996, the Milan criteria was published, suggesting that transplanting in early stages of liver cancer is the best way to achieve positive results. The Milan criteria is one single lesion up to 5 centimeters, or 2 to 3 lesions up to 3 centimeters.

The Milan criteria has been questioned over the past couple of years, according to Yao. There have been some cases where patients have been outside of the Milan criteria and responded positively to the transplant treatment.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x